Treatment with zuranolone, a novel oral antidepressant for postpartum depression, raises important questions for breastfeeding individuals. While recent studies show minimal transfer into breast milk, we do not yet have enough information to recommend breastfeeding while taking zuranolone.
An individualized, collaborative approach to decision-making helps mothers navigate complex choices with confidence, ensuring the well-being of their child, while attending to their own mental health.
While zuranolone may show promise for the treatment of depressive episodes in patients with bipolar disorder, more research is needed.
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy but ignored or diminished the risks associated with untreated depression in the mother.
In a recent study from Mass General Hospital, researchers examined whether information included in the medical record at the time of discharge after delivery could help us to identify individuals at increased risk for postpartum depression.
Postpartum anxiety is a common and often under-recognized condition that affects a substantial proportion of new mothers.
For new moms, breastfeeding is often more difficult than anticipated. In fact, feeding challenges are actually the norm, not the exception.
There are so many opinions about infant feeding - and it may seem like there is a single “right” way to feed your baby.
While the 2025 report indicates that the United States has made progress in training and deploying more maternal mental health providers, the risk for maternal mental health disorders is actually rising.
The Research Hub is a curated source of the latest research, clinical insights, and practical tools for moms and providers.
